Detection of serum VEGF and MMP‑9 levels by Luminex multiplexed assays in patients with breast infiltrative ductal carcinoma

  • Authors:
    • Junying Zhang
    • Li Yin
    • Jianzhong Wu
    • Ye Zhang
    • Tao Xu
    • Rong Ma
    • Haixia Cao
    • Jinhai Tang
  • View Affiliations

  • Published online on: April 14, 2014     https://doi.org/10.3892/etm.2014.1685
  • Pages: 175-180
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

The aim of the present study was to assess the effect of the combined detection of serum vascular endothelial growth factor (VEGF) and matrix metalloproteinase‑9 (MMP‑9) by Luminex multiplexed assays for the diagnosis, treatment and prognosis of breast cancer. Preoperative levels of serum VEGF and MMP‑9 were detected via a lipid chip‑based method in 301 breast cancer cases, 83 breast fibroadenoma cases and 40 healthy adults. Postoperative levels of VEGF and MMP‑9 were also detected in 118 breast cancer cases. The levels of serum VEGF and MMP‑9 in patients with breast infiltrative ductal carcinoma (IDC) were higher than those in the breast fibroadenoma and healthy control groups (P<0.05); there was no statistically significant difference between the breast fibroadenoma and healthy groups (P>0.05). The levels of VEGF and MMP‑9 were shown to correlate with the clinical stage, tumor size and the lymph node metastasis status. However, the levels were not associated with age or gender (P>0.05). In addition, the serum level of MMP‑9 exhibited a significantly correlation with the VEGF level (r=0.601, P<0.001). Subgroup analysis revealed that in patients with IDC, serum levels of VEGF and MMP‑9 prior to surgery were significantly higher than those following surgery (P<0.05). Therefore, the serum levels of VEGF and MMP‑9 can be used as markers for the diagnosis of breast IDC and may also be valuable for the prediction of lymph nodes metastasis.
View Figures
View References

Related Articles

Journal Cover

July-2014
Volume 8 Issue 1

Print ISSN: 1792-0981
Online ISSN:1792-1015

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Zhang J, Yin L, Wu J, Zhang Y, Xu T, Ma R, Cao H and Tang J: Detection of serum VEGF and MMP‑9 levels by Luminex multiplexed assays in patients with breast infiltrative ductal carcinoma. Exp Ther Med 8: 175-180, 2014
APA
Zhang, J., Yin, L., Wu, J., Zhang, Y., Xu, T., Ma, R. ... Tang, J. (2014). Detection of serum VEGF and MMP‑9 levels by Luminex multiplexed assays in patients with breast infiltrative ductal carcinoma. Experimental and Therapeutic Medicine, 8, 175-180. https://doi.org/10.3892/etm.2014.1685
MLA
Zhang, J., Yin, L., Wu, J., Zhang, Y., Xu, T., Ma, R., Cao, H., Tang, J."Detection of serum VEGF and MMP‑9 levels by Luminex multiplexed assays in patients with breast infiltrative ductal carcinoma". Experimental and Therapeutic Medicine 8.1 (2014): 175-180.
Chicago
Zhang, J., Yin, L., Wu, J., Zhang, Y., Xu, T., Ma, R., Cao, H., Tang, J."Detection of serum VEGF and MMP‑9 levels by Luminex multiplexed assays in patients with breast infiltrative ductal carcinoma". Experimental and Therapeutic Medicine 8, no. 1 (2014): 175-180. https://doi.org/10.3892/etm.2014.1685